FDA Grants Orphan Drug Designation to March Biosciences for T-Cell Lymphoma
By Daniella Parra March Biosciences was granted an orphan drug designation from the FDA to MB-105, its CD5-targeted CAR-T ...
March Biosciences Receives FDA Orphan Drug Designation for MB-105, a First-in-Class CD5 CAR-T Cell Therapy, for T-Cell Lymphoma
Company prepares to advance to Phase 2 clinical trial in early 2025HOUSTON, Jan. 28, 2025 (GLOBE NEWSWIRE) -- March Biosciences (March Bio), an ...
Pharmabiz1d
March Biosciences receives US FDA orphan drug designation for MB-105 to treat relapsed/refractory CD5-positive T-cell lymphoma
Biosciences receives US FDA orphan drug designation for MB-105 to treat relapsed/refractory CD5-positive T-cell lymphoma: Houston Thursday, January 30, 2025, 17:00 Hrs [IST] ...
PCRX Stockholders Should Contact Shareholder Rights Firm Robbins For Information About The Class Action Against Pacira Biosciences, Inc.
About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance ...
PCRX Stockholders Have Opportunity to Lead Pacira BioSciences, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
NEW YORK CITY, NY / ACCESS Newswire / January 31, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm ...
Targeted Oncology2d
FDA Grants Orphan Drug Designation to MB-105 for R/R T-Cell Lymphoma
MB-105, a first-in-class CD5-targeted CAR T-cell therapy, received FDA orphan drug designation for relapsed/refractory T-cell ...
bovnews8d
Why Ventyx Biosciences Inc (VTYX) Stock is Currently -1.57% Off from Its 20-Day SMA?
Ventyx Biosciences Inc (VTYX) stock saw a modest uptick, ending the day at $2.16 which represents a slight increase of $0.08 or 3.85% from the prior close of $2.08. The stock opened at $2.05 and ...
bovnews3d
Why Did Sagimet Biosciences Inc (SGMT) Stock Rise 10.00% to $4.62?
Sagimet Biosciences Inc (SGMT) stock saw a modest uptick, ending the day at $4.62 which represents a slight increase of $0.42 or 10.00% from the prior close of $4.2. The stock opened at $4.29 and ...
Fintel on MSN7d
Piper Sandler Initiates Coverage of Bright Minds Biosciences (DRUG) with Overweight Recommendation
Fintel reports that on January 23, 2025, Piper Sandler initiated coverage of Bright Minds Biosciences (NasdaqCM:DRUG) with a ...
The Bakersfield Californian8d
PACIRA BIOSCIENCES SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF ...
ClaimsFiler, a FREE shareholder information service, reminds investors that they have until March 14, 2025 to file lead plaintiff applications in a ...
Bay Area biotech firm IGM Biosciences, once worth billions, guts staff with 73% layoff
IGM Biosciences is laying off 100 workers as it shuts down two research projects, causing the Mountain View company's stock to tank.
Yahoo Finance17d
Valent BioSciences Announces Launch of the Biostimulant Innovator of the Year Award for Farmers
January 14, 2025--(BUSINESS WIRE)--Valent BioSciences in partnership with Meister ... by someone else at BiostimulantInnovator.com through March 12, 2025. "Valent BioSciences is looking forward ...